Voronoi, Inc. Logo

Voronoi, Inc.

Biotech firm developing therapeutics using an AI drug discovery platform.

310210 | KO

Overview

Corporate Details

ISIN(s):
KR7310210000
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 에스동 18층, 연수구

Description

Voronoi, Inc. is a biotechnology company that specializes in the research and development of novel therapeutics for challenging diseases. The company's core expertise lies in creating innovative small molecule kinase inhibitors and target protein degrader drugs. Utilizing its proprietary AI-powered drug discovery platform, VORONOMICS, Voronoi accelerates the identification and optimization of promising drug candidates. This platform enables the rapid design of therapies with high selectivity and brain penetration, primarily targeting various forms of cancer and other difficult-to-treat conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2022-11-09 00:00
기업설명회(IR)개최
Korean HTML 6.8 KB
2022-10-28 00:00
주주총회소집공고
Korean HTML 78.4 KB
2022-10-07 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 67.0 KB
2022-09-30 00:00
주주총회소집결의
Korean HTML 5.9 KB
2022-09-30 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.2 KB
2022-09-13 00:00
투자판단관련주요경영사항(고형암(폐암, 흑색종, 대장암 등) 치료를 위한 경구용 인산화효소 저해 물질 기술이전(License-Out, L/O) …
Korean HTML 12.3 KB
2022-08-31 00:00
[기재정정]투자판단관련주요경영사항(신규 표적치료제 연구개발을 위한 기술도입 계약 체결)
Korean HTML 17.5 KB
2022-08-29 00:00
투자판단관련주요경영사항(신규 표적치료제 연구개발을 위한 기술도입 계약 체결)
Korean HTML 12.0 KB
2022-08-17 00:00
투자판단관련주요경영사항(VRN07(ORIC-114) 관련 마일스톤 기술료 수령)
Korean HTML 8.5 KB
2022-08-12 00:00
반기보고서 (2022.06)
Korean HTML 1.5 MB
2022-07-29 00:00
투자판단관련주요경영사항(신규 표적치료제 연구개발을 위한 기술도입 계약 체결)
Korean HTML 12.6 KB
2022-07-28 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 94.7 KB
2022-07-22 00:00
투자판단관련주요경영사항(신규 표적치료제 연구개발을 위한 기술도입 계약 체결)
Korean HTML 12.2 KB
2022-07-01 00:00
주식등의대량보유상황보고서(약식)
Korean HTML 56.3 KB
2022-06-28 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 115.0 KB

Automate Your Workflow. Get a real-time feed of all Voronoi, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Voronoi, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Voronoi, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.